Metagenomi, Inc.

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MGX and other ETFs, options, and stocks.

About MGX

Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene editing toolbox, therapeutic focus, and processing discovery platform.

CEO

Brian C. Thomas

CEOBrian C. Thomas

Employees

202

Employees202

Headquarters

Emeryville, California

HeadquartersEmeryville, California

Founded

2016

Founded2016

Employees

202

Employees202

MGX Key Statistics

Market cap

62.24M

Market cap62.24M

Price-Earnings ratio

-0.79

Price-Earnings ratio-0.79

Dividend yield

—

Dividend yield—

Average volume

351.17K

Average volume351.17K

High today

$1.70

High today$1.70

Low today

$1.49

Low today$1.49

Open price

$1.53

Open price$1.53

Volume

497.85K

Volume497.85K

52 Week high

$8.17

52 Week high$8.17

52 Week low

$1.23

52 Week low$1.23

Analyst ratings

83%

of 6 ratings

Buy

83.3%

Hold

16.7%

Sell

People also own

Based on the portfolios of people who own MGX. This list is generated using Robinhood data, and it’s not a recommendation.